Travere Therapeutics
TVTX
#4107
Rank
โ‚น260.16 B
Marketcap
โ‚น2,820
Share price
-3.12%
Change (1 day)
84.35%
Change (1 year)

Revenue for Travere Therapeutics (TVTX)

Revenue in 2025 (TTM): โ‚น43.08 Billion

According to Travere Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น45.46 Billion. an increase over the revenue in the year 2024 that were of โ‚น20.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Travere Therapeutics from 2011 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น44.05 B120.23%
2024 โ‚น20.00 B65.44%
2023 โ‚น12.09 B-21.7%
2022 โ‚น15.44 B-8.81%
2021 โ‚น16.93 B16.74%
2020 โ‚น14.50 B16%
2019 โ‚น12.50 B8.87%
2018 โ‚น11.48 B16.09%
2017 โ‚น9.89 B8.98%
2016 โ‚น9.07 B36.75%
2015 โ‚น6.63 B271.38%
2014 โ‚น1.78 B
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น59.49 B 30.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น20.94 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA